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Adhesive Hydrogels for Maxillofacial Tissue Regeneration 
Using Minimally Invasive Procedures
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Degradable materials are used clinically 
to repair damaged musculoskeletal tis-
sues, particularly cartilage in the knee, 
using procedures such as matrix-assisted 
autologous chondrocyte transplantation 
(MACT).[1] However, there are currently 
no similar procedures that surgically place 
degradable materials with cells or regen-
erative factors into maxillofacial tissues to 
foster the repair of muscle, bone, or car-
tilage. The lack of materials-based regen-
erative strategies for maxillofacial tissues 
stems from the strict design criteria that 
govern materials surgically placed in the 
head. Ideally, materials should be suit-
able for minimally invasive procedures, 
as they minimize the potential for nerve 
injury and infection.[2] However, limited 
surgical access and the complex and small 
anatomical structures in the head make 
standard arthroscopic MACT-like proce-
dures unfeasible, particularly because in 
maxillofacial applications adhesion of the 
material to the damaged tissue is likely 
Minimally invasive surgical procedures aiming to repair damaged maxillofacial 
tissues are hampered by its small, complex structures and difficult surgical 
access. Indeed, while arthroscopic procedures that deliver regenerative mate-
rials and/or cells are common in articulating joints such as the knee, there 
are currently no treatments that surgically place cells, regenerative factors or 
materials into maxillofacial tissues to foster bone, cartilage or muscle repair. 
Here, hyaluronic acid (HA)-based hydrogels are developed, which are suitable 
for use in minimally invasive procedures, that can adhere to the surrounding 
tissue, and deliver cells and potentially drugs. By modifying HA with both 
methacrylate (MA) and 3,4-dihydroxyphenylalanine (Dopa) groups using a 
completely aqueous synthesis route, it is shown that MA-HA-Dopa hydrogels 
can be applied under aqueous conditions, gel quickly using a standard surgical 
light, and adhere to tissue. Moreover, upon oxidation of the Dopa, human 
marrow stromal cells attach to hydrogels and survive when encapsulated 
within them. These observations show that when incorporated into HA-based 
hydrogels, Dopa moieties can foster cell and tissue interactions, ensuring 
surgical placement and potentially enabling delivery/recruitment of regenera-
tive cells. The findings suggest that MA-HA-Dopa hydrogels may find use in 
minimally invasive procedures to foster maxillofacial tissue repair.
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necessary. Therefore, a therapy that could deliver a material to 
stimulate repair, like MACT, but via a minimally invasive proce-
dure suitable for maxillofacial applications, has the potential to 
transform the treatment of a range of degenerative and trauma-
related maxillofacial disorders.
Regenerative therapies that aim to deliver a material to max-
illofacial tissues are subject to numerous design limitations. 
First, for many applications, the material should bond to the 
tissue to facilitate integration. For example, unlike in the knee, 
where cartilaginous defects leave a reservoir in which a repara-
tive solution/material can be placed, the fibrocartilage of the 
temporomandibular joint (TMJ) (Figure S2, Supporting Infor-
mation), which might similarly benefit from MACT, is only a 
few hundred microns thick.[3] Therefore, adhesivity is likely 
required to ensure correct placement. The material should also 
fully degrade, and importantly for maxillofacial applications 
which abut the brain, must be completely nontoxic. Moreover, 
the material should ideally be inexpensive, injectable, easily 
manufactured from materials already approved for clinical use 
in maxillofacial applications, and suitable for delivery using 
equipment available in standard surgical theatres. In addition, 
the material must be amenable to cross-linking under aqueous 
conditions (submerged in water), as minimally invasive maxil-
lofacial procedures are often carried out with saline perfusion.
Hyaluronic acid (HA) is a hydrophilic polysaccharide com-
posed of repeating disaccharide units of N-acetylglucosamine 
and D-glucuronic acid. HA possesses carboxyl and hydroxyl 
groups on its backbone suitable for chemical modification,[4,5] 
allowing it to be cross-linked to form hydrogels. Moreover, HA 
can be safely degraded by hyaluronidases, which are ubiquitous 
in vivo. However, HA is nonadhesive, limiting surgical place-
ment, and provides no sites for integrin-mediated interactions 
with cells, which may preclude invasion by endogenous cells. 
3,4-dihydroxyphenylalanine (Dopa) contains catechol functional 
groups, the active component of the mussel foot protein, and 
is known to strongly adhere to inorganic and organic materials 
through both covalent and noncovalent interactions.[6] More-
over, its simple chemical structure allows it to be tethered to a 
range of synthetic and natural polymers.[6]
To create HA-based hydrogels that are potentially suitable for 
minimally invasive surgical procedures in maxillofacial appli-
cations, we carried out a double modification of 100–150 kDa 
HA to add both MA and Dopa groups using an aqueous 
synthesis route (Figure 1A,B). 1H NMR analysis of MA-HA-
Dopa  confirmed successful modification of the HA backbone 
(Figures S3 and S4, Supporting Information), and demon-
strated that by modifying the molar ratios of methacrylic anhy-
dride and dopamine hydrochloride to HA, we could achieve 
both low and high degrees of methacrylation and dopamina-
tion with a total degree of modification of between 9% and 
35% (Figure 1C). Stable hydrogels could then be formed in the 
presence of a cross-linker upon application of a standard clin-
ical blue light (400–500 nm, 400–600 mW cm−2,[7] widely avail-
able in surgical theatres) (Figure 1D). Nonaqueous protocols 
for adding Dopa to synthetic and natural polymers have been 
reported;[8,9] however, our aqueous synthesis avoids the use 
of potentially toxic solvents such as dichloromethane, which 
has been linked to facial nerve paralysis.[10] Indeed, avoiding 
potential toxins is particularly important in  maxillofacial 
 applications where biomaterial-mediated neurotoxicity has 
been reported.[11]
1% and 3% solutions of 100–150 kDa HA have low viscosi-
ties (Figure 1E), rendering precise surgical application trouble-
some. As we aimed to create a material that could be injected, 
we first modified the viscosity of MA-HA-Dopa by adding 
2% unmodified 1 MDa HA. The addition of unmodified HA 
increased the extensional viscosities of all formulations by 
approximately one order of magnitude placing them within the 
range of reported viscosities for clinically relevant materials that 
are similarly applied by syringe.[12] We then optimized hydrogel 
gelation by cross-linking the material’s MA groups with di-thiol 
linear poly(ethylene glycol) (PEG) (significantly less toxic than 
standard dithiothreitol, Figure S5, Supporting Information), 
in the presence of nontoxic concentrations of the visible light 
photo-initiator Eosin Y (Figure S6, Supporting Information). 
Upon irradiation, Eosin Y subtracts a hydrogen from the thiol 
group, leaving a thiyl-radical to undergo a thiol-ene reaction 
with a MA group.[13]
The clinical application of in situ gelling materials requires 
the material to set quickly (≈4 min). Therefore, we next used 
small amplitude oscillatory shear rheology as a function of 
time to monitor gelation (Figure 1F and Figures S7–S10 and 
Table S1: Supporting Information). We first observed that for 
all MA-HA and MA-HA-Dopa (low) formulations, the addition 
of 2% 1 MDa HA did not have an adverse effect on gelation 
time. However, while MA-HA and MA-HA-Dopa formulations 
with low degrees of Dopa (with the exception of 1%, without 
unmodified HA) gelled in less than 4 min (taken as the cross-
over between G′ and G″), MA-HA-Dopa with high degrees of 
Dopa gelled more slowly (>4 min) or not at all. We expect our 
hydrogels to cross-link through thiol-ene radical addition reac-
tions. However, catechols can scavenge free radicals, acting as 
polymerization inhibitors.[14] Here, catechol’s ability to scav-
enge free radicals appeared to inhibit thiol-ene type cross-links 
by reducing the number of thiyl radicals available to crosslink 
the hydrogels with increasing Dopa modification. Although 
Dopa can also react with free thiols upon oxidation to its qui-
none form, during photoinitiated cross-linking Dopa exists 
predominantly in its reduced form.[15] In short, likely by scav-
enging free radicals, hydrogels containing more Dopa form 
fewer crosslinks, an effect that has been previously described 
in catechol-functionalized thiol-ene polymer networks used as 
adhesives.[16] We then assessed MA-HA-Dopa’s ability to cross-
link under aqueous conditions. We found that MA-HA-Dopa 
could be pipetted and cross-linked while fully immersed in 
buffer and still form stable hydrogels (Figure 1G and Movie 
S1: Supporting Information). Taken together, these observa-
tions suggest that nontoxic MA-HA-Dopa hydrogels are suitable 
for injection and can cross-link in an appropriate time frame 
during minimally invasive procedures in which the joint space 
is perfused with buffer. Moreover, the material can potentially 
be placed while a patient is prone and molded many times, if 
necessary, prior to gelation.
Dopa is recognized for its adhesive properties; however, 
stickiness requires the Dopa to be oxidized (Figure 2A).[6,8] Oxi-
dation can be achieved by adding sodium periodate or hydrogen 
peroxide,[8] but these can be biologically toxic. Therefore, we 
next aimed to determine if we could achieve Dopa oxidation 
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under physiological conditions that would promote tissue inter-
actions. After 24 h in cell culture medium, MA-HA-Dopa hydro-
gels turned brown, indicating Dopa oxidation[8] (Figure 2B). 
This was confirmed by colorimetric measurements (Figure 2C), 
and absorption between 250–500 nm continued to increase 
over 72 h, confirming that atmospheric oxygen was sufficient 
to oxidize the Dopa moiety. However, oxidation could be slowed 
by maintaining hydrogels under hypoxic conditions (5% O2), 
showing that lower, tissue-like levels of O2, could also foster 
the process. Next, to determine if the Dopa moiety allowed 
Adv. Healthcare Mater. 2020, 1901134
Figure 1. Monomer synthesis and hydrogel formation. A) Synthesis of MA-HA through reaction of HA with methacrylic anhydride; B) Synthesis of 
MA-HA-Dopa by coupling MA-HA with dopamine; C) Quantification of HA methacrylation and dopamination; D) Reaction schematic demonstrating 
the formation of hydrogels. Upon blue light exposure, Eosin Y deprotonates di-thiol PEG, allowing it to react with methacrylate moieties on HA leading 
to a formation of kinetic chains. This process reduces Eosin Y to a colorless state; E) Viscosity of 1% and 3% (w/v) precursor solutions with and 
without the addition of 2% (w/v) unmodified 1 MDa HA. Plot shows means and standard deviations, n = 3; F) Gelation times for different hydrogel 
compositions. Gelation times were grouped so that light color indicates fast gelation and darker colors show slower gelation; G) Images showing in 
aqua application of viscous solution and gelation (see also Movie S1 in the Supporting Information), Scale bar = 10 mm.
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for tissue interactions, we formed MA-HA and MA-HA-Dopa 
hydrogels within a circular defect punched out of porcine artic-
ular cartilage. We then either actively oxidized the Dopa (NaIO4) 
or allowed it to undergo passive oxidation in cell culture media 
before measuring the force required to push the hydrogel out 
of the tissue. We found that both actively and passively oxidized 
Dopa-modified hydrogels required significantly higher push 
out forces than their MA-HA counterparts (Figure 2D). To fur-
ther demonstrate hydrogel-tissue interactions, we then placed 
MA-HA and MA-HA-Dopa hydrogels along the cut surfaces of a 
mouse hind limb muscle (Figure 2E and Figures S11 and S12: 
Supporting Information). While MA-HA hydrogels fell away 
from the tissue upon manipulation, MA-HA-Dopa hydrogels 
bonded to the tissue and remained adherent even as the muscle 
was physically manipulated (Movie S2, Supporting Informa-
tion), an effect that was maintained after 5 days in  culture 
(Movie S3, Supporting Information).
Materials-based strategies to regenerate cartilage, bone and 
muscle often call for the presence of cells that can secrete 
tissue-specific ECM.[17] Therefore, we next aimed to study cell 
interactions with MA-HA-Dopa hydrogels. We first seeded 
17IA4 cells on the surface of hydrogels and examined their 
attachment. In line with previous observations,[5,18] cells 
do not adhere to MA-HA hydrogels (Figure 3A); however, 
16 h after seeding, 17IA4 cells were adherent to MA-HA-Dopa 
hydrogels. HA has no sites for integrin-mediated interactions, 
so cells do not attach to it, even in the presence of serum pro-
teins. Therefore, these observations suggest that Dopa fostered 
integrin-mediated interactions with the hydrogel, likely by 
binding  proteins[6,19] through which cells attached. Many tissue 
engineering strategies also aim to deliver cells within a mate-
rial. Therefore, we also encapsulated primary human marrow 
stromal cells (hMSC) within hydrogels and found that the addi-
tion of Dopa significantly increased cell viability (Figure 3B and 
Adv. Healthcare Mater. 2020, 1901134
Figure 2. Dopa oxidation of hydrogels and tissue interactions. A) Diagram highlighting how Dopa oxidation impacts protein, cell and tissue interac-
tions with hydrogels; B) Images of hydrogels captured directly after gelation (left) or after 24 h incubation in cell culture media (right) showing that 
the hydrogel becomes brown indicating oxidation of the Dopa; Scale bar = 10 mm; C) Colorimetric measurements of Dopa oxidation in hydrogels 
maintained in cell culture media under standard or hypoxic (5% O2) conditions; D) Force required to push hydrogel (3%, high MA, low Dopa; high 
MA, no Dopa) out of circular defect created in porcine articular cartilage, either after being actively oxidized with NaIO4 or passively oxidized in cell 
culture media over 72 h. Plots show means and standard deviations, n = 3; unpaired t-test (two-tailed, **p < 0.01, ****p < 0.0001); E) Images showing 
hydrogel (3%, high MA, low Dopa) adherent to muscle tissue (top). As the damaged muscle tissue is pulled apart, the hydrogel remains adherent to 
the tissue surfaces (bottom) (see also Movies S2 and S3 in the Supporting Information).
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Figure S13: Supporting Information). This confirmed previous 
reports that hMSC can survive within HA-based hydrogels 
lacking adhesive motifs,[20] but that the addition of Dopa could 
enhance cell survival. Taken together, these observations show 
that by providing sites for protein interaction and thus integrin-
mediated interactions, MA-HA-Dopa hydrogels can potentially 
deliver viable cells or be infiltrated by endogenous cells made 
available using procedures such as microfracture.[21]
As hydrogel physical properties will influence both their 
performance in vivo and subsequent cell response,[22] we 
next examined hydrogel stiffness (G′) and swelling behavior. 
3% hydrogels tended to be stiffer and swell more than those 
formed with 1% (Figure 3C and Figure S14 and Tables S2–S4: 
Supporting Information). Moreover, and in line with observa-
tions of gelling time, more extensive Dopa modification tended 
to result in lower values of G′. We then examined hydrogel 
 degradation in the presence of hyaluronidase and confirmed 
that all compositions were degradable, but that degradation 
tended to be slower in compositions with higher levels of MA, 
lower levels of Dopa and in the presence of unmodified 1 MDa 
HA (Figure 3D and Figure S15: Supporting Information), in 
line with the catechol-mediated negative impact on network 
formation. These observations were in line with previous 
reports of degradability in HA with similar degrees of modi-
fication.[23] The values of G′ we observed here are lower than 
those of many maxillofacial tissues. It is possible to make HA-
based hydrogels stiffer;[18] however, this requires more exten-
sive chemical modification, which can render the material 
nondegradable. However, hydrogels are suitable for infiltra-
tion within porous  load-bearing materials, which have recently 
been used to resurface the articulating surfaces of the TMJ in 
an open procedure.[24] Therefore, combining the MA-HA-Dopa 
Adv. Healthcare Mater. 2020, 1901134
Figure 3. Hydrogel interactions with cells and physical characterization. A) Bright-field images of 17IA4 cells attached to MA-HA and MA-HA-Dopa 
hydrogels after 18 h of culture. Very few cells were observed attached to MA-HA hydrogels. Scale bar = 200 µm; B) hMSC survival after 24 h encapsula-
tion within hydrogels. In 3% hydrogels, cells show significantly higher viability in MA-HA-Dopa hydrogels compared to MA-HA hydrogels. n = 3 biolog-
ical replicates, 300 cells per condition, Fisher’s exact test, **p < 0.01; C) Stiffness as determined by the elastic modulus G′ after 4 min light exposure. G′ 
values were grouped such that lighter colors indicate softer and darker colors show stiffer hydrogels; D) Time for full enzymatic degradation of different 
hydrogel formulations. Lighter colors indicate fast degradation and darker colors show slower degradation. X indicates the absence of gel formation.
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with a porous scaffold could provide mechanical support while 
retaining the benefits of the MA-HA-Dopa hydrogel for cell/
drug delivery.
Finally, as the shelf life of viscous hydrogel precursors will 
impact their suitability for clinical applications, we next com-
pared gelation after storage at room temperature (RT) and 4 °C 
for up to 8 days. While low MA hydrogel compositions stored 
for 1 or 8 days had stiffnesses that were significantly lower than 
those of freshly prepared hydrogels, suggesting that the func-
tional cross-linking groups were lost during storage, material 
prepared with high MA modification, and particularly those 
with low Dopa, formed stable hydrogels with similar stiff-
nesses to freshly prepared material (Figures S16–S20, Sup-
porting Information). These observations not only show that 
MA-HA-Dopa precursor solutions can be stored for at least 1 
week prior to use, but also suggest that our chemical strategy 
does not promote the spontaneous formation of Dopa-Dopa 
cross-links. Moreover, combined with our observation that high 
Dopa formulations either gelled more slowly than their low/No 
Dopa counterparts or not at all further suggests that our chem-
ical strategy does not permit the Dopa moiety to participate in 
hydrogel cross-linking. Taken together, these data suggest that 
MA-HA-Dopa formulations with high degrees of methacryla-
tion and low degrees of dopamination gel within a suitable 
time frame, can be stored prior to use, and have physical and 
adhesive properties appropriate for use in minimally invasive 
maxillofacial applications.
Maxillofacial tissues are amenable to regeneration. For 
example, Undt et al. showed that the cartilaginous surfaces 
of the TMJ could be regenerated upon surgical placement of 
appropriate cells and materials.[24] However, in a case series in 
7 patients in which autologous chondrocytes combined with a 
collagen sponge were used to treat severe degeneration of the 
articular surfaces of the TMJ, two open surgical procedures 
were required. Here, we identified HA-based hydrogel com-
positions with mechanical, biological, adhesive and surgical 
handling properties suitable for delivery via a single minimally 
invasive procedure, with or without autologous cells. Adhesive 
materials for cartilage repair have been previously reported; 
however, 2-step procedures whereby an adhesive intermediate 
is “painted” onto the native tissue to foster interactions with 
the hydrogel[25] are unlikely to be amenable to minimally inva-
sive procedures and the difficult surgical access characteristic 
of maxillofacial tissues. Others have reported the use of qui-
none-modified materials to foster tissue adhesion, but these 
often require oxidizing the material with harsh reagents.[8,26] 
Moreover, in many strategies Dopa itself acts as a cross-linker, 
restricting potential tissue interactions. Our observations here 
suggest that MA-HA-Dopa hydrogels can foster tissue adhe-
sion and cell attachment in the absence of harsh chemical 
treatments and complicated surgical procedures, potentially 
providing a first-of-its-kind therapy for damaged maxillofacial 
tissues.
Experimental Section
Details of the materials and experimental methods are available in the 
Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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